Targets in Gene Therapy 2011
DOI: 10.5772/17424
|View full text |Cite
|
Sign up to set email alerts
|

Gene Therapy of the Heart through Targeting Non-Cardiac Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 85 publications
(75 reference statements)
0
1
0
Order By: Relevance
“…On the other hand, the adeno-associated viral system is affected by neutralizing antibodies, which will significantly reduce the transduction efficiency 41 – 43 . In contrast, lentiviral systems allow stable genome integration into the host cells and have the added advantage of high transduction efficiency in hard-to-transfect cells and cardiovascular gene therapy 6 , 44 . The balance of important features in lentiviral systems makes it a suitable system for long-term gene delivery.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, the adeno-associated viral system is affected by neutralizing antibodies, which will significantly reduce the transduction efficiency 41 – 43 . In contrast, lentiviral systems allow stable genome integration into the host cells and have the added advantage of high transduction efficiency in hard-to-transfect cells and cardiovascular gene therapy 6 , 44 . The balance of important features in lentiviral systems makes it a suitable system for long-term gene delivery.…”
Section: Discussionmentioning
confidence: 99%